Parasitosis con manifestaciones clínicas neurológicas y cardíacas

  1. Torres, A. Hernández
  2. Elisa García Vázquez 1
  3. Escudero, E. Moral
  4. Martínez, J.A. Herrero
  5. Gómez, J. Gómez
  6. Hernández, M. Segovia
  1. 1 Universidad de Murcia
    info

    Universidad de Murcia

    Murcia, España

    ROR https://ror.org/03p3aeb86

Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Any de publicació: 2018

Sèrie: 12

Número: 58

Pàgines: 3416-3421

Tipus: Article

DOI: HTTPS://DOI.ORG/10.1016/J.MED.2018.06.004 DIALNET GOOGLE SCHOLAR

Altres publicacions en: Medicine: Programa de Formación Médica Continuada Acreditado

Resum

Parasitic infections, which were rare in our setting until recently, are now becoming increasingly common due to migratory movements, international travel and immunosuppression. These infections should therefore be considered when making a differential diagnosis between certain clinical conditions, including diseases of the heart and nervous system. In cases of cardiac involvement with parasitic infections, the primary production mechanism of these parasites entails their invasion of the myocardium and pericardium, which, in turn, gives rise to an inflammatory response. Chagas disease, African trypanosomiasis, toxoplasmosis, trichinosis and infections caused by free-living amoebae typically affect the myocardium and result in the onset of myocarditis or cardiomyopathy. In cases of amebiasis and echinococcosis, the most affected structure is the pericardium, which consequently results in the onset of pericardial effusion, tamponade, acute pericarditis or constrictive pericarditis. Schistosomiasis, for its part, affects the pulmonary vasculature and is a noteworthy cause of pulmonary hypertension and pulmonary heart disease (cor pulmonale). Parasitic infections of the nervous system are also a frequent cause of morbidity and mortality. Meningoencephalitis, encephalitis and the growth of space-occupying lesions in cases of echinococcosis, cysticercosis or toxoplasmosis are the primary forms of parasitic cerebral infections.

Referències bibliogràfiques

  • Nunes MC, Guimarães Júnior MH, Diamantino AC, Gelape CL, Ferrari TC. Cardiac manifestations of parasitic diseases. Heart. 2017;103(9):651-8.
  • Solomon T, Kneen R. Neurological presentations. Tropical medicine. Lecture notes. 7th ed. Oxford: Wiley Blackwell; 2014. p. 16-23.
  • Krishna S, Stich A. African trypanosomiasis: Clinical manifesta-tions, diagnosis, and treatment.
  • Adalid-Peralta L, Sáenz B, Fragoso G, Cárdenas G. Understanding hostparasite relationship: the immune central nervous system microenviron-ment and its effect on brain infections. Parasitology. 2017:1-12.
  • Clerinx J, Soentjens P. Epidemiology, pathogenesis, and clinical manifestations of schistosomiasis.
  • Nourbakhsh A, Vannemreddy P, Minagar A, Toledo EG, Palacios E, Nanda A. Hydatid disease of the central nervous system: a review of literature with an emphasis on Latin American countries. Neurol Res. 2010;32(3):245-51.
  • Ruiz S, García-Vázquez E, Picazo R, Hernández A, Herrero JA, Gómez J. La neurocisticercosis en Murcia. Rev Clin Esp. 2011; 211(3):133-8.
  • Thompson H, Thakur K. Infections of the central nervous system in returning travelers and inmigrants. Curr Infect Dis Rep. 2017;19(11):45.
  • Bruschi F, Brunetti E, Pozio E. Neurotrichinellosis. Handb Clin Neurol. 2013;114:243-9.
  • Maldonado-Barrera CA, Campos-Esparza MD, Muñoz-Fernández L, Victoria-Hernández JA, Campos-Rodríguez R, Talamás Rohana P. Clinical case of cerebral amebiasis caused by E. histolytica. Parasitol Res. 2012;110(3):1291-6.
  • Gandhi RT. Toxoplasmosis in HIV infected patients.
  • Breman JG. Clinical manifestations of malaria in nonpregnant adults and children.
  • Ray HN, Doshi D, Rajan A, Singh AK, Singh SB, Das MK. Cardiovascular involvement in severe malaria: A prospective study in Ranchi, Jharkhand. J Vector Borne Dis. 2017;54(2):177-82.
  • Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373(14):1295-306.
  • Bern C. Chagas disease in the immunosuppressed host.
  • Mensa J, Gatell JM, García-Sánchez JE, Letang E, López- Suñé E, Marco F. Guía de terapéutica antimicrobiana. Barcelona: Editorial Antares; 2017.
Fuente de los datos: Dialnet